606 results on '"van Veldhuisen, D J"'
Search Results
52. P566Activated amyloid-beta pathways in patients with atrial fibrillation and heart failure, a pathway analysis in BIOSTAT
53. Tumour biomarkers: association with heart failure outcomes
54. Erythropoietin treatment in patients with chronic heart failure: a meta-analysis
55. Risk of bias in meta-analysis on erythropoietin-stimulating agents in heart failure
56. Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure
57. Zorg rondom hartfalen
58. Predictive utility of high-sensitivity troponin-T for new-onset heart failure is higher in women than in men
59. Genetic risk prediction of atrial fibrillation in a contemporary heart failure cohort
60. Anthropometric measurements of central adiposity are superior predictors of heart failure in the general population - data of PREVEND
61. The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study
62. Diabetes is associated with unique pathological mechanisms in heart failure
63. Dose-finding study of imidapril, a novel angiotensin converting enzyme inhibitor, in patients with stable chronic heart failure
64. Gender-related differences in left ventricular structural and functional responses to hypertension
65. Non-cardiac complications during pregnancy in women with isolated congenital pulmonary valvar stenosis
66. Pregnancy and delivery in women after Fontan palliation
67. Abstracts of papers and posters
68. Abstracts of papers clinical pharmacological meeting
69. Secondary prevention with folic acid: results of the Goes extension study
70. Pregnancy, fertility, and recurrence risk in corrected tetralogy of Fallot
71. Maternal right ventricular function, uteroplacental circulation in first trimester and pregnancy outcome in women with congenital heart disease
72. New Pharmacological Strategies in Chronic Heart Failure
73. The Role of Vascular Failure in Heart Failure
74. Gated blood-pool SPECT automated versus manual left ventricular function calculations
75. Searching for dose-response in HF clinics
76. Evaluation of right ventricular function by NuSMUGA software: gated blood-pool SPECT vs. first-pass radionuclide angiography
77. Identification of a specific pattern of downregulation in expression of isoforms of vascular endothelial growth factor in dilated cardiomyopathy
78. ECG determinants in adult patients with chronic right ventricular pressure overload caused by congenital heart disease: relation with plasma neurohormones and MRI parameters
79. Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques
80. Quantitative assessment of the pressure and volume overloaded right ventricle: imaging is a real challenge
81. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction
82. Comparison of losartan and captopril in ELITE II
83. Cardiovascular Morbidity in Long-Term Survivors of Metastatic Testicular Cancer
84. Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables
85. Absolute and functional iron deficiency in heart failure defined and described
86. Increased interleukin 6 levels at 24 hours after ST-elevation myocardial infarction are associated with decreased cardiac function at 4 months
87. Obesity-related reduction in NT-proBNP levels in healthy individuals is greater in women compared to men
88. Novel endotypes in heart failure: effects on guideline-directed medical therapy
89. Novel endotypes in heart failure: effects on guideline-directed medical therapy
90. Rapid progression of pericardial malignant mesothelioma
91. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure
92. Effects of lacidipine on peak oxygen consumption, neurohormones and invasive haemodynamics in patients with mild to moderate chronic heart failure
93. Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH
94. 203Impact of mineralocorticoid receptor antagonists on sudden cardiac death in patients with heart failure and left ventricular systolic dysfunction: a meta-analysis of three randomized controlled trials
95. P2294Four targeted therapies and less than four targeted therapies of underlying conditions against conventional therapy in atrial fibrillation - data from the RACE 3 study
96. P910Beware of making dose comparisons for efficacy in post-hoc analyses of achieved dose in up-titrating studies: lessons from the EMPHASIS trial
97. 5223Absolute and functional iron deficiency in heart failure defined and described
98. P1175Determinants of progression of persistent to permanent atrial fibrillation - data from the RACE 3 study
99. 54Treating underlying conditions improves quality of life in patients with persistent atrial fibrillation and heart failure - data from the RACE 3 study
100. Arrythythmias in hypertrophic cardiomyopathy: prognostic significance and clinical relevance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.